These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 464094)

  • 1. Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.
    Elahi D; Andersen DK; Brown JC; Debas HT; Hershcopf RJ; Raizes GS; Tobin JD; Andres R
    Am J Physiol; 1979 Aug; 237(2):E185-91. PubMed ID: 464094
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
    Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
    Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
    Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
    J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical studies with gastric inhibitory polypeptide.
    Brown JC; Otte S
    World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of gastric inhibitory polypeptide, glucose, and arginine on insulin and glucagon secretion from the perfused rat pancreas.
    Pederson RA; Brown JC
    Endocrinology; 1978 Aug; 103(2):610-5. PubMed ID: 744105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of glucagon, gastric inhibitory polypeptide, pancreatic polypeptide and somatostatin on beta-adrenergically induced insulin secretion in the mouse.
    Ahrén B; Lundquist I
    Diabete Metab; 1982 Sep; 8(3):209-12. PubMed ID: 6128264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of gastric inhibitory polypeptide (GIP) as the enterogastrone.
    Soon-Shiong P; Debas HT; Brown JC
    J Surg Res; 1979 Jun; 26(6):681-6. PubMed ID: 156287
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of cholecystokinin, gastric inhibitory polypeptide, and secretin on insulin and glucagon secretion in rats.
    Szecówka J; Lins PE; Efendić S
    Endocrinology; 1982 Apr; 110(4):1268-72. PubMed ID: 7037370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric inhibitory polypeptide, cholecystokinin, and secretin effects on insulin and glucagon secretion by islet cultures.
    Fujimoto WY; Williams RH; Ensinck JW
    Proc Soc Exp Biol Med; 1979 Mar; 160(3):349-53. PubMed ID: 372950
    [No Abstract]   [Full Text] [Related]  

  • 10. Stimulation by gastric inhibitory polypeptide of insulin and glucagon secretion by rat islet cultures.
    Fujimoto WY; Ensinck JW; Merchant FW; Williams RH; Smith PH; Johnson DG
    Proc Soc Exp Biol Med; 1978 Jan; 157(1):89-93. PubMed ID: 341178
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans.
    Christensen M; Vedtofte L; Holst JJ; Vilsbøll T; Knop FK
    Diabetes; 2011 Dec; 60(12):3103-9. PubMed ID: 21984584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
    Meneilly GS; Ryan AS; Minaker KL; Elahi D
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
    Christensen MB
    Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of arginine and gastric inhibitory polypeptide on insulin release in man.
    Elahi D; Raizes GS; Andres R; Hershcopf RJ; Muller DC; Tobin JD; Andersen DK
    Am J Physiol; 1982 May; 242(5):E343-51. PubMed ID: 7044143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of porcine GIP on insulin secretion and glucose clearance in the pig.
    Wolffbrandt KH; Damm Jørgensen K; Moody AJ; Pedersen PC
    Horm Metab Res; 1986 Mar; 18(3):159-62. PubMed ID: 3516832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of (Pro-)insulin biosynthesis and release by gastric inhibitory polypeptide in isolated islets of rat pancreas.
    Schäfer R; Schatz H
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):493-500. PubMed ID: 382725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GIP-like immunoreactivity in glucagon cells. Interactions between GIP and glucagon on insulin release.
    Ahrén B; Håkanson R; Lundquist I; Sjölund K; Sundler F
    Acta Physiol Scand; 1981 Jul; 112(3):233-42. PubMed ID: 7027739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GIP and the entero-insular axis.
    Brown JC; Otte SC
    Clin Endocrinol Metab; 1979 Jul; 8(2):365-77. PubMed ID: 383323
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholecystokinin and gastric inhibitory polypeptide not glucagonotropic in dogs.
    Sirinek KR; Levine BA; Crockett SE; Cataland S
    J Surg Res; 1980 Apr; 28(4):367-72. PubMed ID: 7366196
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man.
    Sarson DL; Wood SM; Holder D; Bloom SR
    Diabetologia; 1982 Jan; 22(1):33-6. PubMed ID: 7037506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.